| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2864867 | The American Journal of the Medical Sciences | 2009 | 4 Pages |
Abstract
Rifampin hepatotoxicity associated with treatment of latent tuberculosis infection is rare. Our report suggests that hepatotoxicity is more likely in patients with baseline hepatic dysfunction and the need for increased vigilance in monitoring transaminases in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Francis F. MD, Elizabeth A. PhD, Anna R. BSc, Timothy H. PharmD,